Cargando…

A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer whose incidence and mortality rate are increasing. Identifying immune-related lncRNAs and constructing a model would probably provide new insights into biomarkers and immunotherapy for ccRCC and aid in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zedan, Tang, Yanlin, Liu, Yanjun, Zhuang, Hongkai, Lin, Enyu, Xie, Lu, Feng, Xiaoqiang, Tian, Kaiwen, Zeng, Jiayi, Liu, Jiumin, Yu, Yuming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339875/ https://www.ncbi.nlm.nih.gov/pubmed/34368371 http://dx.doi.org/10.1155/2021/9921466

Ejemplares similares

Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft
por: Zhang, Zedan, et al.
Publicado: (2020)

Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
por: Zhang, Zedan, et al.
Publicado: (2020)

Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma
por: Lin, Enyu, et al.
Publicado: (2021)

Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy
por: Lin, Enyu, et al.
Publicado: (2022)

Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma
por: Tang, Yanlin, et al.
Publicado: (2023)

Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma
por: Zeng, Jiayi, et al.
Publicado: (2023)

Identification of a basement membrane-based risk scoring system for prognosis prediction and individualized therapy in clear cell renal cell carcinoma
por: Tang, Yanlin, et al.
Publicado: (2023)

Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhang, Zedan, et al.
Publicado: (2022)

A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma
por: Liu, Haoran, et al.
Publicado: (2020)

Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma
por: Lai, Jiayi, et al.
Publicado: (2023)

Screening for the Key lncRNA Targets Associated With Metastasis of Renal Clear Cell Carcinoma
por: Liu, Huibin, et al.
Publicado: (2016)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network
por: Gong, Ke, et al.
Publicado: (2021)

Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma
por: Yang, Wuping, et al.
Publicado: (2022)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma
por: Gao, Lei, et al.
Publicado: (2020)

lncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-β-Induced Epithelial-Mesenchymal Transition
por: Wang, Peng, et al.
Publicado: (2020)

Identification of a lncRNA-associated competing endogenous RNA-regulated network in clear cell renal cell carcinoma
por: Liu, Beibei, et al.
Publicado: (2019)

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
por: Dou, Qian, et al.
Publicado: (2021)

Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
por: Xue, Sheng, et al.
Publicado: (2022)

Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma
por: Wang, Gang, et al.
Publicado: (2022)

Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization
por: Lan, Huihua, et al.
Publicado: (2017)

Construction of an individualized clinical prognostic index based on ubiquitination-associated lncRNA in clear cell renal cell carcinoma patients
por: Liu, Kun, et al.
Publicado: (2022)

A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Retraction Notice to: lncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-β-Induced Epithelial-Mesenchymal Transition
por: Wang, Peng, et al.
Publicado: (2022)

The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma
por: Cox, A., et al.
Publicado: (2020)

An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma
por: Tang, Cheng, et al.
Publicado: (2021)

A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma
por: Zhang, Hui, et al.
Publicado: (2022)

A novel coagulation-related lncRNA predicts the prognosis and immune of clear cell renal cell carcinoma
por: Wu, Wensong, et al.
Publicado: (2023)

lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression
por: Yang, Tao, et al.
Publicado: (2017)

Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model
por: Qu, GenYi, et al.
Publicado: (2023)

Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma
por: Li, Tinghao, et al.
Publicado: (2022)

Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2019)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma
por: Zhao, Liwen, et al.
Publicado: (2022)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
por: Shen, Junlin, et al.
Publicado: (2023)

A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vuua4nd6o673g52vucj5a733m8